Institute of Anatomy, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Department of Nephrology, University Hospital Zurich, Zurich, Switzerland.
Pflugers Arch. 2022 Aug;474(8):813-827. doi: 10.1007/s00424-022-02701-y. Epub 2022 May 14.
Damage to the proximal tubule (PT) is the most frequent cause of acute kidney injury (AKI) in humans. Diagnostic and treatment options for AKI are currently limited, and a deeper understanding of pathogenic mechanisms at a cellular level is required to rectify this situation. Metabolism in the PT is complex and closely coupled to solute transport function. Recent studies have shown that major changes in PT metabolism occur during AKI and have highlighted some potential targets for intervention. However, translating these insights into effective new therapies still represents a substantial challenge. In this article, in addition to providing a brief overview of the current state of the field, we will highlight three emerging areas that we feel are worthy of greater attention. First, we will discuss the role of axial heterogeneity in cellular function along the PT in determining baseline susceptibility to different metabolic hits. Second, we will emphasize that elucidating insult specific pathogenic mechanisms will likely be critical in devising more personalized treatments for AKI. Finally, we will argue that uncovering links between tubular metabolism and whole-body homeostasis will identify new strategies to try to reduce the considerable morbidity and mortality associated with AKI. These concepts will be illustrated by examples of recent studies emanating from the authors' laboratories and performed under the auspices of the Swiss National Competence Center for Kidney Research (NCCR Kidney.ch).
近端肾小管(PT)损伤是人类急性肾损伤(AKI)最常见的原因。目前,AKI 的诊断和治疗选择有限,需要更深入地了解细胞水平的发病机制,以纠正这种情况。PT 的代谢非常复杂,与溶质转运功能密切相关。最近的研究表明,PT 代谢在 AKI 期间发生重大变化,并突出了一些潜在的干预靶点。然而,将这些见解转化为有效的新疗法仍然是一个巨大的挑战。在本文中,除了简要概述该领域的现状外,我们还将重点介绍三个我们认为值得更多关注的新兴领域。首先,我们将讨论沿 PT 的细胞功能的轴向异质性在确定对不同代谢打击的基线易感性方面的作用。其次,我们将强调阐明特定损伤的发病机制对于设计针对 AKI 的更个体化治疗可能至关重要。最后,我们认为,揭示肾小管代谢与全身内稳态之间的联系将确定减少与 AKI 相关的相当大的发病率和死亡率的新策略。这些概念将通过作者实验室的最新研究示例来说明,并在瑞士国家肾脏研究卓越中心(NCCR Kidney.ch)的支持下进行。